Response to pre-radiation chemotherapy as a predictor of survival in patients with newly diagnosed malignant astrocytoma: A north central cancer treatment group (NCCTG) study

被引：0
|
作者：
Jaeckle, K
Ballman, K
O'Fallon, J
Scheithauer, B
Giannini, C
Moynihan, T
Buckner, J
机构：
[1] Mayo Clin, Jacksonville, FL USA
[2] Mayo Clin, Rochester, MN USA
来源：
NEURO-ONCOLOGY | 2004年 / 6卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：376 / 376
页数：1
相关论文
共 50 条
  • [31] THE VALUE OF ADJUVANT CHEMOTHERAPY (PREDNISONE, CCNU AND VINCRISTINE) IN THE MANAGEMENT OF NEWLY DIAGNOSED MEDULLOBLASTOMA, MALIGNANT ASTROCYTOMA AND BRAIN-STEM GLIOMA - RESULTS FROM THE CHILDRENS CANCER STUDY-GROUP (CCG)
    ALLEN, J
    ERTEL, I
    EVANS, A
    HAMMOND, D
    JENKIN, D
    SPOSTO, R
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1984, 11 (02) : 324 - 324
  • [32] NCCTG N0572 phase I/II trial of sorafenib and temsirolimus in patients with recurrent glioblastoma: A North Central Cancer Treatment Group study.
    Jaeckle, K. A.
    Schiff, D.
    Anderson, S. K.
    Galanis, E.
    Stella, P. J.
    Flynn, P. J.
    Sarkaria, J. N.
    Scheithauer, B. W.
    Erickson, B. J.
    Buckner, J. C.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [33] CPT-11 for bile-duct and gallbladder carcinoma - A phase II north central cancer treatment group (NCCTG) study
    Alberts, SR
    Fishkin, PA
    Burgart, LJ
    Cera, PJ
    Mahoney, MR
    Morton, RF
    Johnson, PA
    Nair, S
    Goldberg, RM
    JOURNAL OF GASTROINTESTINAL CANCER, 2002, 32 (2-3) : 107 - 114
  • [34] Psychiatric morbidity and survival in newly diagnosed treatment-naive cancer patients - A study from Malaysia
    Ariaratnam, Suthahar
    Devi, Ambigga
    Kaur, Gurpreet
    Sinniah, Dhachayani
    Suleiman, Adlina
    Thambu, Maniam
    Ismail, Fuad
    BIOMEDICAL RESEARCH-INDIA, 2008, 19 (02): : 113 - 116
  • [35] Gemcitabine and epirubicin in patients with malignant pleural mesothelioma (MPM): A North Central Cancer Treatment Group phase II study.
    Okuno, SH
    Delaune, R
    Sloan, J
    Aubry, MC
    Foster, N
    Rowland, K
    Mailliard, J
    Nikcevich, D
    Jett, J
    Bot, B
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 686S - 686S
  • [36] Gemcitabine and docetaxel in patients with measurable unresectable or metastatic hepatocellular carcinoma (HCC), a North Central Cancer Treatment Group (NCCTG) phase II trial
    Kim, GP
    Alberts, SR
    Tschetter, LK
    Fitch, TR
    Dakhil, SR
    Morlan, BW
    Sargent, DJ
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 380S - 380S
  • [37] Hepatic Arterial Infusion and Systemic Chemotherapy After Multiple Metastasectomy in Patients With Colorectal Carcinoma Metastatic to the Liver: A North Central Cancer Treatment Group (NCCTG) Phase II Study, 92-46-52
    Bolton, John S.
    O'Connell, Michael J.
    Mahoney, Michelle R.
    Farr, Gist H., Jr.
    Fitch, Tom R.
    Maples, William J.
    Nagorney, David M.
    Rubin, Joseph
    Fuloria, Jyotsna
    Steen, Preston D.
    Alberts, Steven R.
    CLINICAL COLORECTAL CANCER, 2012, 11 (01) : 31 - 37
  • [38] Progressive anaplastic transformation of infiltrative gliomas: A correlative clinicopathologic study of primary and recurrent tumors from patients treated on north central cancer treatment group (NCCTG) trials
    Jaeckle, K. A.
    Decker, P. A.
    Ballman, K. V.
    Flynn, P. J.
    Giannini, C.
    Scheithauer, B. W.
    Jenkins, R. B.
    Buckner, J. C.
    NEURO-ONCOLOGY, 2006, 8 (04) : 459 - 459
  • [39] NORTH CENTRAL CANCER TREATMENT GROUP PHASE I TRIAL N057K OF EVEROLIMUS (RAD001) AND TEMOZOLOMIDE IN COMBINATION WITH RADIATION THERAPY IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME
    Sarkaria, Jann N.
    Galanis, Evanthia
    Wu, Wenting
    Peller, Patrick J.
    Giannini, Caterina
    Brown, Paul D.
    Uhm, Joon H.
    McGraw, Steven
    Jaeckle, Kurt A.
    Buckner, Jan C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : 468 - 475
  • [40] Elapsed radiation therapy treatment time as a predictor of survival in patients with advanced head and neck cancer who receive chemotherapy and radiation therapy
    Alden, ME
    OReilly, RC
    Topham, A
    Lowry, LD
    Brodovsky, H
    Curran, WJ
    RADIOLOGY, 1996, 201 (03) : 675 - 680
12345